Janus Henderson Group’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $107M | Buy |
2,533,405
+1,026,969
| +68% | +$43.2M | 0.05% | 254 |
|
2025
Q1 | $58.3M | Buy |
1,506,436
+576,913
| +62% | +$22.3M | 0.03% | 341 |
|
2024
Q4 | $71.6M | Buy |
929,523
+405,957
| +78% | +$31.3M | 0.04% | 320 |
|
2024
Q3 | $30.1M | Buy |
523,566
+141,881
| +37% | +$8.15M | 0.02% | 496 |
|
2024
Q2 | $15.9M | Buy |
381,685
+71,626
| +23% | +$2.98M | 0.01% | 614 |
|
2024
Q1 | $18.9M | Buy |
+310,059
| New | +$18.9M | 0.01% | 571 |
|
2022
Q2 | – | Sell |
-222,263
| Closed | -$34M | – | 2662 |
|
2022
Q1 | $34M | Sell |
222,263
-575
| -0.3% | -$88K | 0.02% | 609 |
|
2021
Q4 | $65.9M | Buy |
222,838
+4,227
| +2% | +$1.25M | 0.03% | 468 |
|
2021
Q3 | $60.6M | Buy |
218,611
+20,045
| +10% | +$5.56M | 0.03% | 495 |
|
2021
Q2 | $54.4M | Buy |
198,566
+127,673
| +180% | +$35M | 0.02% | 550 |
|
2021
Q1 | $34.8M | Buy |
70,893
+11,068
| +19% | +$5.44M | 0.02% | 642 |
|
2020
Q4 | $49.4M | Buy |
+59,825
| New | +$49.4M | 0.02% | 541 |
|